Drug Shortage Report for TEVA-CHLORPROMAZINE
| Report ID | 252069 |
| Drug Identification Number | 00232807 |
| Brand name | TEVA-CHLORPROMAZINE |
| Common or Proper name | CHLORPROMAZINE 50MG TABS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CHLORPROMAZINE |
| Strength(s) | 50.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | N05AA |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-03-05 |
| Estimated end date | 2025-04-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-03-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-03-20 | French | Compare |
| v5 | 2025-03-20 | English | Compare |
| v4 | 2025-03-13 | French | Compare |
| v3 | 2025-03-13 | English | Compare |
| v2 | 2025-03-06 | French | Compare |
| v1 | 2025-03-06 | English | Compare |
Showing 1 to 6 of 6